Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Popescu, Cristina ^a   Arama, Victoria ^a   Gliga, Smaranda ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN; ALPHA2A INTERFERON; ANTIVIRUS AGENT; IBUPROFEN; MACROGOL DERIVATIVE;

ACUTE PERICARDITIS; ADULT; ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; BLOOD PRESSURE; BLOOD TOXICITY; CASE REPORT; CLINICAL FEATURE; DRUG SAFETY; DRUG WITHDRAWAL; ENDOCRINE DISEASE; EYE TOXICITY; FEMALE; HEART SOUND; HEART TAMPONADE; HEPATITIS C; HUMAN; LABORATORY TEST; LEUKOPENIA; PERICARDIAL EFFUSION; PERICARDITIS; TACHYCARDIA; TACHYPNEA; THROMBOCYTOPENIA; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; TREATMENT WITHDRAWAL;

ACUTE DISEASE; ADULT; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IBUPROFEN; INTERFERON ALFA-2A; PERICARDITIS; POLYETHYLENE GLYCOLS; RIBAVIRIN; WITHHOLDING TREATMENT;

EID: 79953171208     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-30     Document Type: Article

References (16)

1. Dusheiko G. Side effects of alpha interferon in chronic hepatitis C. Hepatology 1997, 26:112S-121S. 10.1002/hep.510260720, 9305675.
2. Negro F. Adverse effects of drugs in the treatment of viral hepatitis. Best Pract Res Clin Gastroenterol 2010, 24:183-92. 10.1016/j.bpg.2009.10.012, 20227031.
3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981, 30:239-45. 10.1038/clpt.1981.154, 7249508.
4. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005, 23:275-306. 10.1146/annurev.immunol.23.021704.115633, 15771572.
5. Rechciński T, Matusik D, Rudziński T, et al. Cardiotoxic properties of interferon: aggravation of atrio-ventricular block during treatment of chronic hepatitis C with peginterferon--a case report. Pol Arch Med Wewn 2007, 117:49-52.
6. Outzen MA, Crowley S. Interferons Play a Central Role in the Natural Defense and Therapeutic Management of Hepatitis C: A Review. The Internet Journal of Gastroenterology 2007, 5(2).
7. Takahashi H, Nishimura M, Sakamoto M, Ikegaki I, Nakanishi T, Yoshimura M. Effects of interleukin-1 beta on blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats. Am J Hypertens 1992, 5:224-9.
8. Maisch B, Seferović PM, Ristić AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004, 25:587-610. 10.1016/j.ehj.2004.02.002, 15120056.
9. Benjamini O, Kimhi O, Lishner M. Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b. Isr Med Assoc J 2007, 9:486-7.
10. Fava S, Luoni M, Stioui S. Pericarditis during interferon-alpha therapy in chronic myelogenous leukemia. Haematologica 1996, 81:484.
11. Sikole A, Dzekova P, Selja N, et al. Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy. Ren Fail 2007, 29:961-6. 10.1080/08860220701641579, 18067041.
12. Suárez A, Vallina E, Navascués CA, et al. Mixed type-II cryoglobulinemia associated with a chronic hepatitis C virus infection. Rev Clin Esp 1993, 192:325-6.
13. Boonen A, Stockbrügger RW, van der Linden S. Pericarditis after therapy with interferon-alpha for chronic hepatitis. C Clin Rheumatol 1999, 18:177-9.
14. Nishio K, Konndo T, Shunichi O, et al. Pericarditis and chronic inflammatory demyelinating polyneuropathy during therapy with pegylated interferon alfa-2a for chronic hepatitis C. World J Hepatol 2010, 2:358-61. 10.4254/wjh.v2.i9.358, 2999299, 21161021.
15. Gressens B, Gohy P. Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C. Acta Gastroenterol Belg 2004, 67:301-2.
16. Wisniewski B, Denis J, Fischer D, Labayle D. Pericarditis secondary to interferon alpha in chronic hepatitis C. Gastroenterol Clin Biol 2004, 28:315-6. 10.1016/S0399-8320(04)94929-9, 15094688.